Stay updated on High-Dose Eteplirsen in DMD Clinical Trial
Sign up to get notified when there's something new on the High-Dose Eteplirsen in DMD Clinical Trial page.

Latest updates to the High-Dose Eteplirsen in DMD Clinical Trial page
- ChecktodayNo Change Detected
- Check8 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check15 days agoNo Change Detected
- Check22 days agoChange DetectedThe page has undergone significant changes in the study details for Duchenne Muscular Dystrophy (DMD), including the removal of specific inclusion and exclusion criteria and a revision update from v2.14.4 to v2.15.0.SummaryDifference21%
- Check29 days agoChange DetectedThe page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to December 20, 2024.SummaryDifference0.6%
- Check37 days agoChange DetectedThe page has been updated to reflect a new version (v2.14.3) and a new last update date of March 25, 2025, replacing the previous estimated update date of December 20, 2024.SummaryDifference0.4%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check87 days agoChange DetectedThe web page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
Stay in the know with updates to High-Dose Eteplirsen in DMD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the High-Dose Eteplirsen in DMD Clinical Trial page.